Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : MW-401
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Discovery
Recipient : Expert Systems
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Mwyngil Therapeutics Licenses GPR75 Modulators from Expert Systems Inc.
Details : Through the licensing deal for MW-401, targeting GPR75, the agreement aims to advance key focus areas in North America.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
November 06, 2025
Lead Product(s) : MW-401
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Discovery
Recipient : Expert Systems
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Reset All
